Merith Basey, executive director of Patients for Affordable Drugs, countered that the measure is “simply put, a giveaway to pharma.”
“Americans are asking Congress to do more to lower drug prices, and believe that drug prices are far too high,” she added. “This is going exactly in the opposite direction that voters are demanding.”
